These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17854871)

  • 61. [Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].
    Zhang SH; Chen J; Jiang M; Zhen YS
    Yao Xue Xue Bao; 2008 Jun; 43(6):601-4. PubMed ID: 18822962
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.
    Maurer BJ; Kalous O; Yesair DW; Wu X; Janeba J; Maldonado V; Khankaldyyan V; Frgala T; Sun BC; McKee RT; Burgess SW; Shaw WA; Reynolds CP
    Clin Cancer Res; 2007 May; 13(10):3079-86. PubMed ID: 17505011
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice.
    Ye H; Jin L; Hu R; Yi Z; Li J; Wu Y; Xi X; Wu Z
    Biomaterials; 2006 Dec; 27(35):5958-65. PubMed ID: 16949149
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism.
    Lewis KC; Zech LA; Phang JM
    Cancer Res; 1994 Aug; 54(15):4112-7. PubMed ID: 8033144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 66. N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death.
    Tosetti F; Venè R; Arena G; Morini M; Minghelli S; Noonan DM; Albini A
    Mol Pharmacol; 2003 Mar; 63(3):565-73. PubMed ID: 12606763
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.
    Makovitzki A; Fink A; Shai Y
    Cancer Res; 2009 Apr; 69(8):3458-63. PubMed ID: 19351852
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lipid nano-bubble combined with ultrasound for anti-keloids therapy.
    Wang XQ; Li ZN; Wang QM; Jin HY; Gao Z; Jin ZH
    J Liposome Res; 2018 Mar; 28(1):5-13. PubMed ID: 27733083
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.
    Nieto K; Pei P; Wang D; Mallery SR; Schwendeman SP
    Int J Pharm; 2018 Mar; 538(1-2):48-56. PubMed ID: 29170116
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
    Oridate N; Suzuki S; Higuchi M; Mitchell MF; Hong WK; Lotan R
    J Natl Cancer Inst; 1997 Aug; 89(16):1191-8. PubMed ID: 9274913
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preliminary results of nanopharmaceuticals used in the radioimmunotherapy of ovarian cancer.
    McQuarrie S; Mercer J; Syme A; Suresh M; Miller G
    J Pharm Pharm Sci; 2005 Feb; 7(4):29-34. PubMed ID: 15850546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.
    Sun SY; Yue P; Kelloff GJ; Steele VE; Lippman SM; Hong WK; Lotan R
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):595-601. PubMed ID: 11401908
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells.
    Pergolizzi R; Appierto V; Crosti M; Cavadini E; Cleris L; Guffanti A; Formelli F
    Int J Cancer; 1999 May; 81(5):829-34. PubMed ID: 10328240
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors.
    Basha R; Ingersoll SB; Sankpal UT; Ahmad S; Baker CH; Edwards JR; Holloway RW; Kaja S; Abdelrahim M
    Gynecol Oncol; 2011 Jul; 122(1):163-70. PubMed ID: 21496890
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism.
    Gopal AK; Pagel JM; Hedin N; Press OW
    Blood; 2004 May; 103(9):3516-20. PubMed ID: 14695237
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extraction, purification and antitumor activity of a water-soluble polysaccharide from the roots of Polygala tenuifolia.
    Xin T; Zhang F; Jiang Q; Chen C; Huang D; Li Y; Shen W; Jin Y
    Carbohydr Polym; 2012 Oct; 90(2):1127-31. PubMed ID: 22840049
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo.
    Xie H; Zhu F; Huang Z; Lee MH; Kim DJ; Li X; Lim DY; Jung SK; Kang S; Li H; Reddy K; Wang L; Ma W; Lubet RA; Bode AM; Dong Z
    Carcinogenesis; 2012 Sep; 33(9):1814-21. PubMed ID: 22798378
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ROS mediates 4HPR-induced posttranscriptional expression of the Gadd153 gene.
    Lai WL; Wong NS
    Free Radic Biol Med; 2005 Jun; 38(12):1585-93. PubMed ID: 15917187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention.
    Brewer M; Utzinger U; Satterfield W; Hill L; Gershenson D; Bast R; Wharton JT; Richards-Kortum R; Follen M
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):889-93. PubMed ID: 11489756
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis.
    Zhu K; Fukasawa I; Furuno M; Inaba F; Yamazaki T; Kamemori T; Kousaka N; Ota Y; Hayashi M; Maehama T; Inaba N
    Gynecol Oncol; 2005 May; 97(2):405-9. PubMed ID: 15863137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.